结构式团体心理干预在经肝动脉化疗栓塞术治疗的原发性肝癌患者应用效果研究

doi:10.3969/j.issn.1672-5069.2018.03.046

Abstract

Li Ying, Sun Bo, Wang Xin. Application of structural group psychological intervention in patients with primary liver cancer after receiving percutaneous transhepatic arterial chemoembolization[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 477-478.

References

[1] 刘珩,沙丽艳,王立明,等. 经皮行肝动脉化疗栓塞术PLC患者生活质量与希望水平及应对方式的相关性研究.护理学报,2016,23(6):21-26.
[2] 胡晓晓,姜金霞,邓瑶,等. 综合护理干预对经皮肝动脉化疗栓塞介入治疗PLC患者的效果. 实用临床医药杂志,2017,21(12):91-93,97.
[3] Xing M,Lahti S,Kokabi N,et al.90Y radioembolization lung shunt fraction in primary and metastatic liver cancer as a biomarker for survival. Clin Nucl Med,2016,41(1):21-27.
[4] Kim YI,Park JW,Kwak HW,et al.Long-term outcomes of second treatment after initial transarterial chemoembolization in patients with hepatocellular carcinoma. Liver Int,2014,5(2):52-59.
[5] 张天燕,安波,杨娟丽,等. 结构式团体心理治疗对癌症患者疼痛与抑郁情绪的作用. 重庆医学,2015,44(21):2989-2991.
[6] Philipsen A,Jans T,Graf E,et al.Effects of group psychotherapy,individual counseling,methylphenidate,and placebo in the treatment of adult attention-deficit/hyperactivity disorder:A randomized clinical trial. JAMA Psychiat,2015,72(12):1199-1210.
[7] 邹毓琴,唐成武,鲍鹰,等. 肝动脉化疗栓塞术治疗PLC的综合护理干预.中国现代医生,2014,52(9):105-106,109.
[8] Court H,Greenland K,Margrain TH.Measuring patient anxiety in primary care:Rasch analysis of the 6-item Spielberger State Anxiety Scale. Value Health,2010,13(6):813-819.
[9] 时亚玲. 心理护理干预对PLC患者预后的影响分析.吉林医学,2012,33(27):6034-6035.
[10] 程光荣,郭丽萍. PLC患者接受肝动脉灌注化疗栓塞术后护理康复效果分析. 实用肝脏病杂志,2016,19(6):700-703.
[11] 李聪芳. PLC介入手术治疗的配合及护理.中国现代药物应用,2016,10(3):272-274.
[12] 曹焱,姜峰,张超,等.肝动脉栓塞化疗联合CT引导精准微波消融治疗原发性PLC患者疗效及对外周血T淋巴细胞亚群的影响. 实用肝脏病杂志,2017,20(4):468-471.

[1]	Liu Xing, Zhao Shuli, Zhang Dianlong. Effect of sevoflurane inhalation on hepatic ischemia-reperfusion injury in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(5): 728-731.
[2]	Pei Ying, Huang Feng, Yin Hongzhen, et al. Preliminary study on intestinal microecology in mice with xenograft hepatoma intervened by sodiumnorcantharidate [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 486-489.
[3]	Dai Qingyun, Wang Rundong, Jia Weidong. Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 561-564.
[4]	Cui Faqiang, Li Tao, Wang Zheng, et al. A pilot study on cetuximab and KRAS gene mutation in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 565-568.
[5]	Yang Fucun, Shang Huaixue, Gai Yonghao. Enhanced magnetic resonance imaging by gadolinium disodium sebacate in diagnosis of patients with focal liver lesions [J]. Journal of Practical Hepatology, 2019, 22(4): 577-580.
[6]	Peng Xinjian, Xiao Yuhui, Xu Siding. Diagnostic value of diffusion-weighted magnetic resonance imaging in patients with radiation-induced liver injury with underlying hepatocelullar carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 373-376.
[7]	Zhao Xiaoguang, Shi Yujie. Protective effect of reduced glutathione on liver function in patients with advanced primary liver cancer underwent transarterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 425-428.
[8]	Li Ketian, Shen Mingge, Wang Fengrong, Hu Chunrong, Cao Yujie, Lu Peng. Impact of blood glucose levels on imaging quality of PET/CT examination in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 256-259.
[9]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Efficacy of transcatheter arterial chemoembolization and ultrasound-guided microwave ablation in the treatment of patients with hepatocellular carcinoma at special sites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 260-263.
[10]	Zhang Bangjian, Wei Shoucun, Yang Xiaoyan. Effects of dexmedetomidine combined with propofol anesthesia on perioperative stress response and postoperative recovery quality in patients undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 264-267.
[11]	Zhang Xiaozhou, Shuai Ling, Wang Qingda, Yang Nan. Changes of serum miR-335 levels in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 268-271.
[12]	Xu Dafeng, Zhou Kailun, Li Zhuori, et al.. Preliminary observation of miR-144 liposomes on inhibition of proliferation, migration and invasion of liver cancer cells in vitro and in vivo [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 25-28.
[13]	Li Fang, Zou Guizhou, Gao Yufeng, et al.. Frequency of PD-1 copy number variation in individuals with hepatitis B viral infection [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 37-40.
[14]	Wang Cuixiao, Gao Jing.. Serum Golgi protein 73, lentil lectin-reactive alpha-fetoprotein-L3,AFP andα-L- fucosidase levels in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 113-116.
[15]	Dai Xiaonan, Lyu Jinyan, Weng Wencai, et al.. Expression of IFITM3 in hepatocellular carcinoma and its correlation with intrahepatic tumor recurence after hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 117-120.

Application of structural group psychological intervention in patients with primary liver cancer after receiving percutaneous transhepatic arterial chemoembolization

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments